Retrospective Study
Copyright ©The Author(s) 2025.
World J Cardiol. Jun 26, 2025; 17(6): 106445
Published online Jun 26, 2025. doi: 10.4330/wjc.v17.i6.106445
Table 1 Demographic Characteristics of study participants, n (%)
Parameter
Value
Age (mean ± SD) (years)35.9 ± 3.38
Sex
Male88 (96.7)
Female3 (3.3)
Table 2 Body mass index summary, n (%)
Category (kg/m2)

Underweight (< 18.5)0
Healthy (18.5-24.9)19 (20.87)
Overweight (25-29.9)32 (35.16)
Obese (> 30)40 (43.9)
Body mass index (mean ± SD)30.7 ± 5.8
Table 3 Prevalence of cardiovascular risk factors, n (%)
Risk factor
Measure

HypertensionYes24 (26.37)
No67 (73.63)
DMYes30 (32.97)
No61 (67.03)
Type 1 DM2 (2.2)
Type 2 DM28 (30.76)
Newly diagnosed DM8 (8.79)
DyslipidemiaYes63 (69.23)
No28 (30.76)
Newly diagnosed dyslipidemia25 (39.68)
Smoking statusYes45 (49.45)
No46 (50.54)
Family history of ischemic heart diseaseYes19 (20.88)
No72 (79.12)
Table 4 Patient diagnosis on admission, n (%)
Cause of admission
Measure

STEMIYes52 (57.1)
No39 (42.86)
Anterior STEMI35 (38.46)
Inferior STEMI16 (17.58)
Lateral STEMI1 (1.1)
Non-STEMIYes39 (42.86)
No52 (57.1)
Table 5 Echocardiographic findings, n (%)
Parameter

Segmental wall motion
Normal17 (18.68)
Inferior/posterior hypokinesia20 (21.98)
Anterior-septal hypokinesia9 (10.99)
Apical akinesia6 (6.59)
Anterior and apical hypokinesia20 (21.98)
Global hypokinesia12 (13.19)
Lateral hypokinesia6 (6.59)
Ejection fraction range (mean ± SD)47.8% ± 12.92%
Table 6 Coronary angiography findings, n (%)
Parameter
n = 91
LMNormal86 (94.51)
Significant lesion4 (4.4)
Total occlusion (dissection)1 (1.1)
LADNormal20 (21.98)
Significant lesion23 (25.28)
Non-significant lesion12 (13.19)
Total occlusion18 (19.78)
Subtotal occlusion9 (9.89)
Thrombus4 (4.39)
Bridge3 (3.3)
Total D12 (2.2)
LCXNormal51 (56.04)
Significant lesion16 (17.58)
Non-significant lesion18 (19.78)
Total occlusion3 (3.3)
Subtotal occlusion2 (2.2)
Dissection1 (1.1)
RCANormal41 (45.05)
Significant lesion11 (12.09)
Non-significant lesion20 (21.98)
Total occlusion9 (9.89)
Subtotal occlusion8 (8.79)
Thrombus2 (2.2)
RamusNormal86 (94.51)
Significant lesion1 (1.1)
Non-significant lesion4 (4.4)
n = 79
Culprit arteryLAD51 (56.04)
RCA17 (18.68)
LCX11 (12.09)
n = 84
Frequency of affected vesselsSingle vessel disease66 (72.53)
Two vessel disease8 (8.79)
Three vessel disease5 (5.49)
LM + three vessel disease4 (4.4)
LM + two vessel disease1(1.1)
Table 7 Coronary angiography final diagnosis, n (%)
Final diagnosis
n = 91
Obstructive CAD76 (83.51)
Myocardial infarction with non-obstructive coronary arteries13 (14.28)
Non-obstructive CAD5 (5.5)
Normal coronary6 (6.59)
Takotsubo cardiomyopathy1 (1.1)
Aortic valve insufficiency induced cardiomyopathy1 (1.1)
Coronary artery dissection2 (2.2)
With no obstructive lesion1 (1.1)
With obstructive lesion1 (1.1)
Table 8 Management strategies, n (%)
Conclusion
n = 91
Intervention78 (85.71)
PCITotal number68 (74.72)
PCI with 1 DES57 (62.64)
PCI with 2 DES6 (6.59)
PCI with 3 DES1 (1.1)
PCI with 5 DES1 (1.1)
PCI with 1 DES and 1 DEB1 (1.1)
PCI with 2 DES and 1 DEB1 (1.1)
PCI with 1 DES and 3 DEB1 (1.1)
Thrombus aspiration2 (2.2)
Open heart surgeryTotal number8 (8.79)
MVD for CABG6 (6.59)
MVD for CABG + AVR1 (1.1)
AVR and Bentall procedure1 (1.1)
Medical treatment6 (6.6)
Normal coronaries7 (7.7)
Table 9 Summary of patient characteristics, n (%)
Parameter
Value (n = 91)
Age (years, mean ± SD)35.9 ± 3.4
Male88 (96.7)
Body mass index (kg/m²) (mean ± SD)30.7 ± 5.8
Obese (> 30)40 (43.9)
Overweight (25–29.9)32 (35.2)
Risk factors
Hyperlipidemia63 (69.2)
Smoking45 (49.5)
Diabetes mellitus30 (33.0)
Hypertension24 (26.4)
Family history of CAD18 (20.9)
Presentation
STEMI52 (57.1)
Non-STEMI39 (42.9)
Coronary angiography findings
Obstructive CAD76 (83.51)
Myocardial infarction with non-obstructive coronary arteries13 (14.28)
Coronary artery dissection2 (2.2)
Management
Percutaneous intervention70 (76.92)
Surgery8 (8.79)
Medical treatment6 (6.6)
Normal coronaries7 (7.7)